HIV i-Base

Fit for purpose: antiretroviral treatment optimisation (Feb 2017)

Some ARVs have shown superior or non-inferior efficacy at reduced doses compared to existing recommended ones. These drugs offer improved durability and tolerability, higher bioavailability, lower pill burden, and the potential for fewer side effects. The ARVs are: dolutegravir (DTG), tenofovir alafenamide …

Early reports from CROI 2017

Featured

Ten rapid reports from Seattle… new drugs, dolutegravir monotherapy studies stopped, paediatric formulations, PrEP failure case, good news from brain scans… more to follow…

Pocket guides

i-Base produce a set of small pocket leaflets that are linked to the larger treatment guides. Pocket leaflets Pocket guide to ART Pocket guide to side effects Pocket guide to pregnancy         Detailed booklets Introduction guide to ART Guide …

November/December HTB now online

Featured

Post-US election issue: reports from Glasgow Congress and Research for Preventions meetings, global treatment, EACS guidelines, UK PrEP updates and more…

September/October HTB now online

PrEP safety, side effects of integrase inhibitors, HIV and children and global access to dolutegravir – reports from four meetings + other news including reduced dose maintenance studies…

July/August HTB now online

News from Durban on HIV prevention including TasP and PrEP, paediatrics, TB and cure research – plus news about PrEP in the UK…

PROUD study closes leaving participants with no access to PrEP

Simon Collins, HIV i-Base On 29 July 2016, the PROUD study website announced that the study will close without being able to continue to provide participants with oral PrEP. [1] The press release blames NHS England for cancelling the previous …

May/June HTB now online

NHS decision to block PrEP, reports from BHIVA, EASL, CROI and HIV and Women conferences, use of HPV vaccine – and remembering i-Base founder Paul Blanchard…

March/April HTB now online

Dozens of studies from CROI 2016: PrEP, new HIV drugs, paediatric and access… plus STOP-PRESS news that NHS England blocks PrEP in the UK…

Post navigation